Scancell (LON:SCLP) Stock Price Up 28.3% – Here’s Why

Shares of Scancell Holdings plc (LON:SCLP) traded up 28.3% on Monday . The company traded as high as GBX 10.87 ($0.14) and last traded at GBX 10.87 ($0.14). 7,645,821 shares were traded during trading, an increase of 791% from the average session volume of 858,372 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Price Performance

The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The stock has a 50-day simple moving average of GBX 8.51 and a 200 day simple moving average of GBX 10.85. The company has a market cap of £103.20 million, a P/E ratio of -15.28 and a beta of 0.35.

Scancell (LON:SCLP) last issued its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. On average, equities analysts expect that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.